Published in Expert Rev Pharmacoecon Outcomes Res on December 11, 2014
Potential role of home monitoring to reduce inappropriate shocks in implantable cardioverter-defibrillator patients due to lead failure. Europace (2008) 2.19
Molecular imaging of HER2-expressing malignant tumors in breast cancer patients using synthetic 111In- or 68Ga-labeled affibody molecules. J Nucl Med (2010) 1.75
What can we learn from German health incentive schemes? BMJ (2009) 1.62
Simulated life-threatening emergency during robot-assisted surgery. J Endourol (2014) 1.40
Low-loss hollow-core silica/air photonic bandgap fibre. Nature (2003) 1.32
Results of individual patient dosimetry in peptide receptor radionuclide therapy with 177Lu DOTA-TATE and 177Lu DOTA-NOC. Cancer Biother Radiopharm (2007) 1.23
Balloon osteoplasty--a new technique for minimally invasive reduction and stabilisation of Hill-Sachs lesions of the humeral head: a cadaver study. Int Orthop (2012) 1.20
Patients with type 2 diabetes benefit from primary care-based disease management: a propensity score matched survival time analysis. Popul Health Manag (2012) 1.02
Cost-effectiveness analysis of different screening procedures for type 2 diabetes: the KORA Survey 2000. Diabetes Care (2004) 1.01
Anatomical organization of antennal lobe projection neurons in the moth Heliothis virescens. J Comp Neurol (2007) 0.98
[Evaluating the effectiveness of a disease management program diabetes in the German Statutory Health Insurance: first results and methodological considerations]. Z Evid Fortbild Qual Gesundhwes (2012) 0.95
Uncertainty assessment of input parameters for economic evaluation: Gauss's error propagation, an alternative to established methods. Med Decis Making (2009) 0.93
The evolution of health literacy assessment tools: a systematic review. BMC Public Health (2014) 0.93
Converted lumbar BMD values derived from sagittal reformations of contrast-enhanced MDCT predict incidental osteoporotic vertebral fractures. Calcif Tissue Int (2012) 0.91
Patient preference of ranibizumab treatment regimen for neovascular age-related macular degeneration - monthly injections versus pro re nata. Graefes Arch Clin Exp Ophthalmol (2013) 0.90
Sex differences in treatment patterns of six chronic diseases: an analysis from the German statutory health insurance. J Womens Health (Larchmt) (2008) 0.90
The stability of pseudopeptides bearing sulfoximines as chiral backbone modifying element towards proteinase K. Bioorg Med Chem Lett (2003) 0.90
A national hypertension treatment program in Germany and its estimated impact on costs, life expectancy, and cost-effectiveness. Health Policy (2007) 0.89
Pressure ulcers in older hospitalised patients and its impact on length of stay: a retrospective observational study. J Clin Nurs (2011) 0.88
The Bad Berka dose protocol: comparative results of dosimetry in peptide receptor radionuclide therapy using (177)Lu-DOTATATE, (177)Lu-DOTANOC, and (177)Lu-DOTATOC. Recent Results Cancer Res (2013) 0.88
Generation of megawatt optical solitons in hollow-core photonic band-gap fibers. Science (2003) 0.88
Costs of dialysis--a regional population-based analysis. Nephrol Dial Transplant (2009) 0.88
Cost-effectiveness analysis of FET PET-guided target selection for the diagnosis of gliomas. Eur J Nucl Med Mol Imaging (2012) 0.88
Balloon osteoplasty--a new technique for reduction and stabilisation of impression fractures in the tibial plateau: a cadaver study and first clinical application. Int Orthop (2012) 0.87
Reflections on the changing face of German pharmaceutical policy: how far is Germany from value-based pricing? Pharmacoeconomics (2011) 0.86
Genetic polymorphisms of hemostasis genes and primary outcome of very low birth weight infants. Pediatrics (2006) 0.86
Prolonged intensive care treatment of octogenarians after cardiac surgery: a reasonable economic burden? Interact Cardiovasc Thorac Surg (2013) 0.84
The use of O-(2-18F-fluoroethyl)-L-tyrosine PET for treatment management of bevacizumab and irinotecan in patients with recurrent high-grade glioma: a cost-effectiveness analysis. J Nucl Med (2013) 0.84
Synthesis and structure of novel sugar-substituted bipyridine complexes of rhenium and 99m-technetium. Chemistry (2007) 0.84
Loudness dependence of the auditory evoked N1/P2 component as an indicator of serotonergic dysfunction in patients with schizophrenia--a replication study. Psychiatry Res (2007) 0.84
Epidemic microclusters of blood-culture proven sepsis in very-low-birth weight infants: experience of the German Neonatal Network. PLoS One (2012) 0.84
13C-Labeled metabolic flux analysis of a fed-batch culture of elutriated Saccharomyces cerevisiae. FEMS Yeast Res (2007) 0.83
Cortical and trabecular bone structure analysis at the distal radius-prediction of biomechanical strength by DXA and MRI. J Bone Miner Metab (2012) 0.83
Cost-effectiveness of using clinical risk factors with and without DXA for osteoporosis screening in postmenopausal women. Value Health (2009) 0.82
Ganglia of the tarsal sinus: MR imaging features and clinical findings. Eur J Radiol (2010) 0.82
Cost-effectiveness of a multifactorial fracture prevention program for elderly people admitted to nursing homes. Eur J Health Econ (2014) 0.81
Reproducibility of trabecular bone structure measurements of the distal radius at 1.5 and 3.0 T magnetic resonance imaging. J Comput Assist Tomogr (2012) 0.81
Is prevention of atopic eczema with hydrolyzed formulas cost-effective? A health economic evaluation from Germany. Pediatr Allergy Immunol (2012) 0.81
An unusual cause of oversensing leading to inappropriate ICD discharges. Int J Cardiol (2007) 0.81
Informing Severely III Patients: Needs, Shortcomings and Strategies for Improvement. Breast Care (Basel) (2011) 0.81
Cost-effectiveness of different strategies for selecting and treating individuals at increased risk of osteoporosis or osteopenia: a systematic review. Value Health (2012) 0.81
Out-of-hospital thrombolysis during cardiopulmonary resuscitation in patients with high likelihood of ST-elevation myocardial infarction. Resuscitation (2007) 0.80
Anterior cingulum volumetry, auditory P300 in schizophrenia with negative symptoms. Psychiatry Res (2010) 0.80
DTI detects water diffusion abnormalities in the thalamus that correlate with an extremity pain episode in a patient with multiple sclerosis. Neuroimage Clin (2013) 0.80
Cost effectiveness of rituximab for non-Hodgkin's lymphoma: a systematic review. Pharmacoeconomics (2012) 0.80
Cell population modelling of yeast glycolytic oscillations. Biochem J (2002) 0.80
Barriers in the implementation of interprofessional continuing education programs--a qualitative study from Germany. BMC Med Educ (2014) 0.80
A multi-perspective cost-effectiveness analysis comparing rivaroxaban with enoxaparin sodium for thromboprophylaxis after total hip and knee replacement in the German healthcare setting. BMC Health Serv Res (2012) 0.80
On age-specific variations in income-related inequalities in diabetes, hypertension and obesity. Int J Public Health (2012) 0.80
Breast cancer attributable costs in Germany: a top-down approach based on sickness funds data. PLoS One (2012) 0.79
Budget impact analysis of drugs for ultra-orphan non-oncological diseases in Europe. Expert Rev Pharmacoecon Outcomes Res (2014) 0.79
Cost-effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in newly diagnosed type 2 diabetes in Germany. Int J Technol Assess Health Care (2010) 0.79
BMD measurements of the spine derived from sagittal reformations of contrast-enhanced MDCT without dedicated software. Eur J Radiol (2010) 0.79
Survivor costs in cost-effectiveness analysis. Ann Intern Med (2006) 0.79
Quantification and classification of errors associated with hand-repackaging of medications in long-term care facilities in Germany. Am J Geriatr Pharmacother (2008) 0.79
Odor coding in projection neurons of the honeybee brain. Chem Senses (2005) 0.79
Cost effectiveness of rivaroxaban for stroke prevention in German patients with atrial fibrillation. Pharmacoeconomics (2015) 0.78
Return to sports activity after tibial plateau fractures: 89 cases with minimum 24-month follow-up. Am J Sports Med (2012) 0.78
Cost effectiveness of ultrasound and bone densitometry for osteoporosis screening in post-menopausal women. Appl Health Econ Health Policy (2008) 0.78
Very low birth weight infants as a model to study genetic influences on neonatal weight gain. J Pediatr Gastroenterol Nutr (2008) 0.78
Modifiable behavioral factors as causes of death. JAMA (2004) 0.78
Direct costs of care in germany for children and adolescents with diabetes mellitus in the early course after onset. J Pediatr Endocrinol Metab (2004) 0.78
Cardiotoxicity and cancer therapy: treatment-related cardiac morbidity in patients presenting with symptoms suggestive of heart or lung disease. Oncology (2013) 0.78
The ethics of non-inferiority trials. Lancet (2008) 0.78
Cost effectiveness of external hip protectors in the hospital setting: a modeling study. Nurs Econ (2014) 0.78
Thyroid nodules with indeterminate cytology: molecular imaging with ⁹⁹mTc-methoxyisobutylisonitrile (MIBI) is more cost-effective than the Afirma gene expression classifier. Eur J Nucl Med Mol Imaging (2014) 0.77
Cost-effectiveness of angiotensin-converting enzyme inhibitors for the prevention of diabetic nephropathy in The Netherlands--a Markov model. PLoS One (2011) 0.77
Cost-effectiveness of angiotensin-converting enzyme inhibitors in nondiabetic advanced renal disease. Expert Rev Pharmacoecon Outcomes Res (2011) 0.77
Moving forward with wellness incentives under the Affordable Care Act: lessons from Germany. Issue Brief (Commonw Fund) (2012) 0.77
P300 subcomponents and clinical symptoms in schizophrenia. Int J Psychophysiol (2002) 0.77
Accounting for increased non-target-disease-specific mortality in decision-analytic screening models for economic evaluation. Eur J Health Econ (2012) 0.77
Limitations of N-Terminal Pro-B-Type Natriuretic Peptide in the Diagnosis of Heart Disease among Cancer Patients Who Present with Cardiac or Pulmonary Symptoms. Oncology (2016) 0.77
In-vitro assessment of coronary artery stents in 256-multislice computed tomography angiography. BMC Res Notes (2014) 0.77
Cost effectiveness of the German screen-and-treat strategy for postmenopausal osteoporosis. Pharmacoeconomics (2008) 0.76
Turn formation initiated by a bissulfoximine motif: synthesis and structural investigation. Org Lett (2002) 0.76
Prehospital versus periprocedural abciximab in ST-elevation myocardial infarction treated by percutaneous coronary intervention. Eur J Emerg Med (2008) 0.76
Cost effectiveness of secondary vs tertiary prevention for post-menopausal osteoporosis. Appl Health Econ Health Policy (2011) 0.76
Rhenium and 99m-technetium complexes of monosaccharide based tripodal triamines as potential radio imaging agents. Dalton Trans (2009) 0.76
Talking about life-threatening illness. JPM Patient Information. J Palliat Med (2010) 0.76
Cost-effectiveness analysis of amino acid PET-guided surgery for supratentorial high-grade gliomas. J Nucl Med (2012) 0.76
The economic value of medical technology. Health Aff (Millwood) (2002) 0.75
Caregivers' quality of life and economic evaluations. Pharmacoeconomics (2012) 0.75
Economic evaluation of Sinfrontal in the treatment of acute maxillary sinusitis in adults. Appl Health Econ Health Policy (2009) 0.75
Economic analysis of influenza vaccination and treatment. Ann Intern Med (2003) 0.75
A payer's perspective on the cost effectiveness of gastric bypass surgery. Am J Manag Care (2009) 0.75
Pharmaceutical risk-sharing agreements. Pharmacoeconomics (2009) 0.75
Ethical criteria for allocating health-care resources. Lancet (2009) 0.75
Polymorphisms in FTO and MAF Genes and Birth Weight, BMI, Ponderal Index, Weight Gain in a Large Cohort of Infants with a Birth Weight below 1500 Grams. PLoS One (2013) 0.75
Productivity loss due to irritable bowel syndrome. Arch Intern Med (2003) 0.75
Improving communication of health-related quality of life. JAMA (2003) 0.75
Cost-effectiveness of cardioverter-defibrillators in heart failure patients. Europace (2009) 0.75
Burden-of-disease estimates. Health Aff (Millwood) (2003) 0.75
Economic evaluations alongside equivalence and noninferiority trials. Value Health (2009) 0.75